First-in-human evaluation of a novel poly-L-lactide based sirolimus-eluting bioresorbable vascular scaffold for the treatment of de novo native coronary artery lesions: MeRes-1 trial

Native Coronary Artery ◽

Human Evaluation ◽

TCTAP A-003 First-in-human Evaluation of a Novel Poly-L-lactide Based Sirolimus-eluting Bioresorbable Vascular Scaffold for the Treatment of De Novo Native Coronary Artery Lesions: MeRes-1 Trial

10.1016/j.jacc.2017.03.028 ◽

2017 ◽

Vol 69 (16) ◽

pp. S2

Author(s):

Ashok Seth ◽

Manjunath Cholenahally Nanjappa ◽

Ajaykumar Umakant Mahajan ◽

Viveka Kumar ◽

Parvin Kumar Goel ◽

...

Keyword(s):

Coronary Artery ◽

De Novo ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

Human Evaluation ◽

TCT-312 4-year Clinical Results of a Randomized trial Evaluating the Absorb Bioresorbable Vascular Scaffold vs. Metallic Drug-eluting Stent in de novo Native Coronary Artery Lesions: Data from the ABSORB Japan Trial

10.1016/j.jacc.2018.08.1453 ◽

2018 ◽

Vol 72 (13) ◽

pp. B128-B129

Author(s):

Kengo Tanabe ◽

Ken Kozuma ◽

Takeshi Kimura

Keyword(s):

Coronary Artery ◽

Randomized Trial ◽

De Novo ◽

Clinical Results ◽

Drug Eluting Stent ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

Vascular Scaffold ◽

Drug Eluting

TCT-165 5-Year Clinical Results of a Randomized Trial Evaluating the Absorb Bioresorbable Vascular Scaffold Versus Metallic Drug-Eluting Stent in De Novo Native Coronary Artery Lesions: Data From the ABSORB Japan Trial

10.1016/j.jacc.2019.08.220 ◽

2019 ◽

Vol 74 (13) ◽

pp. B164

Author(s):

Ken Kozuma ◽

Takeshi Kimura ◽

Kengo Tanabe

Keyword(s):

Coronary Artery ◽

Randomized Trial ◽

De Novo ◽

Clinical Results ◽

Drug Eluting Stent ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

Vascular Scaffold ◽

Drug Eluting

FIRST REPORT OF THE THREE YEAR CLINICAL AND MULTI–MODALITY IMAGING RESULTS OF THE ABSORB TRIAL EVALUATING THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS

10.1016/s0735-1097(13)61731-3 ◽

2013 ◽

Vol 61 (10) ◽

pp. E1731 ◽

Cited By ~ 5

Author(s):

Patrick Serruys

Keyword(s):

Coronary Artery ◽

De Novo ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

First Report ◽

Imaging Results ◽

TCT-35 Evaluation of the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold (Absorb BVS) in the Treatment of Patients with de Novo Native Coronary Artery Lesions: 3 Year Clinical Results of the ABSORB Cohort B1 Trial

10.1016/j.jacc.2012.08.043 ◽

2012 ◽

Vol 60 (17) ◽

pp. B11 ◽

Cited By ~ 1

Author(s):

Peter Smits

Keyword(s):

Coronary Artery ◽

De Novo ◽

Clinical Results ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

Vascular Scaffold ◽

Absorb Bvs

EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD (ABSORB BVS) IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 2 YEAR CLINICAL RESULTS OF ABSORB COHORT B TRIAL

10.1016/s0735-1097(12)60320-9 ◽

2012 ◽

Vol 59 (13) ◽

pp. E319 ◽

Cited By ~ 3

Author(s):

Dariusz Dudek

Keyword(s):

Coronary Artery ◽

De Novo ◽

Clinical Results ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

Vascular Scaffold ◽

Absorb Bvs

TCT-32 First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery Lesions

10.1016/j.jacc.2013.08.762 ◽

2013 ◽

Vol 62 (18) ◽

pp. B11 ◽

Cited By ~ 2

Author(s):

Bernard Chevalier

Keyword(s):

Coronary Artery ◽

De Novo ◽

Clinical Results ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

First Report ◽

1968Quantitative angiographic analysis in patients with de novo native coronary artery lesions treated with novel poly-l-lactide based sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 Trial

European Heart Journal ◽

10.1093/eurheartj/ehx502.1968 ◽

2017 ◽

Vol 38 (suppl_1) ◽

Author(s):

R. Costa ◽

A. Seth ◽

P. Chandra ◽

V. Bhal ◽

M. Nanjappa ◽

...

Keyword(s):

Coronary Artery ◽

De Novo ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

THE ABSORB TRIAL: EVALUATION OF THE ABSORB EVEROLIMUS ELUTING BIORESORBABLE VASCULAR SCAFFOLD IN THE TREATMENT OF PATIENTS WITH DE NOVO NATIVE CORONARY ARTERY LESIONS: 4 YEAR CLINICAL RESULTS OF COHORT B

10.1016/s0735-1097(14)61709-5 ◽

2014 ◽

Vol 63 (12) ◽

pp. A1706 ◽

Cited By ~ 1

Author(s):

Evald Hoej Christiansen

Keyword(s):

Coronary Artery ◽

De Novo ◽

Clinical Results ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

Faculty of 1000 evaluation for ABSORB II randomized controlled trial: A clinical evaluation to compare the safety, efficacy, and performance of the Absorb everolimus-eluting bioresorbable vascular scaffold system against the XIENCE everolimus-eluting coronary stent system in the treatment of subjects with ischemic heart disease caused by de novo native coronary artery lesions: Rationale and study design.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717964511.793474479 ◽

2013 ◽

Author(s):

Gregor Theilmeier ◽

Jan Larmann

Keyword(s):

Randomized Controlled Trial ◽

De Novo ◽

Controlled Trial ◽

Coronary Artery Lesions ◽

Native Coronary Artery ◽

Randomized Controlled ◽

Stent System ◽

Vascular Scaffold ◽

And Performance